Given a question and a context passage, generate the answer having the word or phrase from the context passage. Here, the answer should be a shortest continous span from the passage.

Input: Consider Input: Context: It is unanimously accepted that there is an unmet need for pain medications that are both effective and safe. Unfortunately, no really novel analgesics have been approved over the past three decades. In view of both experimental and clinical evidence of a major role for nerve growth factor (NGF) in the generation and maintenance of a wide range of pain states, drug discovery efforts focusing on the development of anti-NGF agents have aroused particular interest. Several humanized anti-NGF monoclonal antibodies (mAbs) have entered clinical trials as potential analgesics. In this respect, tanezumab is at an advanced stage of clinical development while fulranumab, fasinumab and ABT-110, previously known as PG110, are in early phases of clinical development. This Current Opinion article aims at describing the rationale for targeting NGF for pain, reviewing the analgesic efficacy and safety of anti-NGF agents based on data from fully published studies, conference abstracts, and the US Food and Drug Administration (FDA) website, and discussing the possible future of these agents in managing chronic pain. Anti-NGF mAbs produced significant pain relief and functional improvement in patients with osteoarthritis of the knee and/or hip. Conversely, studies in non-specific lower back pain generated mixed results; overall, this condition appeared to be less responsive to anti-NGF agents than osteoarthritis. Finally, there was no conclusive evidence of the effectiveness of anti-NGF mAbs in some types of chronic visceral or neuropathic pain. Furthermore, these studies raised safety concerns about anti-NGF mAbs. As a class, these drugs may cause or worsen peripheral neuropathies. But the most problematic issue-which prompted the FDA to place studies of these compounds on clinical hold in 2010-was rapid joint destruction leading to joint replacement surgery. The aetiologies of these side effects have been much debated and their pathophysiology is poorly understood. After an Arthritis Advisory Committee meeting held in March 2012, pharmaceutical companies negotiated with the FDA on the conditions for restarting clinical studies. Although the FDA lifted its clinical hold, there remain many unresolved issues about the long-term efficacy and safety of anti-NGF mAbs. While acknowledging that the future of these drugs is unforeseeable, it appears that they may not be the safe and effective painkillers that have been awaited for decades. 
 Question: What is the target of tanezumab?

Output: ngf


Input: Consider Input: Context: The immune system usually protects you from pathogens and other causes of disease. When the immune system is working properly, it keeps you from getting sick. But the immune system is like any other system of the body. It can break down or develop diseases. AIDS is an infectious disease of the immune system caused by a virus. Some diseases of the immune system are noninfectious. They include autoimmune diseases and allergies. Does it make sense for an immune system to attack the cells it is meant to protect? No, but an immune system that does not function properly will attack its own cells. An autoimmune disease is a disease in which the immune system attacks the bodys own cells. One example is type 1 diabetes. In this disease, the immune system attacks cells of the pancreas. Other examples are multiple sclerosis and rheumatoid arthritis. In multiple sclerosis, the immune system attacks nerve cells. This causes weakness and pain. In rheumatoid arthritis, the immune system attacks the cells of joints. This causes joint damage and pain. Autoimmune diseases cannot be cured. But they can be helped with medicines that weaken the immune systems attack on normal cells. Other autoimmune diseases include celiac disease (damages to the small intestine), inflam- matory bowel disease (damage to the digestive tract), psoriasis (damage to the skin), and lupus (damage to the joints, skin, kidneys, heart, and lungs). An allergy occurs when the immune system attacks a harmless substance that enters the body from the outside. A substance that causes an allergy is called an allergen. It is the immune system, not the allergen, that causes the symptoms of an allergy. Did you ever hear of hay fever? Its not really a fever at all. Its an allergy to plant pollens. People with this type of allergy have symptoms such as watery eyes, sneezing, and a runny nose. A common cause of hay fever is the pollen of ragweed. Many people are also allergic to poison ivy ( Figure 1.2). Skin contact with poison ivy leads to an itchy rash in people who are allergic to the plant. Ragweed is a common roadside weed found throughout the United States. Many people are allergic to its pollen. Some people are allergic to certain foods. Nuts and shellfish are common causes of food allergies. Other common causes of allergies include: Drugs, such as penicillin. Mold. Dust. The dead skin cells of dogs and cats, called dander. Stings of wasps and bees. Most allergies can be treated with medicines. Medicines used to treat allergies include antihistamines and corticos- teroids. These medicines help control the immune system when it attacks an allergen. Sometimes, allergies cause severe symptoms, a condition known as anaphylaxis. For example, they may cause the throat to swell so it is hard to breathe. Severe allergies may be life threatening. They require emergency medical care. 
 Question: autoimmune diseases can be cured with

Output: autoimmune diseases cannot be cured.


Input: Consider Input: Context: The fighting against youth smoking since I took office I've done everything in my power to protect our children from harm. We've worked to make their streets and their schools safer, and to give them something positive to do after school before their parents get home. We've worked to teach our children that drugs are dangerous, illegal and wrong. Today, I want to talk to you about the historic opportunity we now have to protect our nation's children form an even more deadly threat: smoking. Smoking kills more people every day than AIDS, alcohol, car accidents, murders, suicides, drugs and fires combined. Nearly 90 percent of those smokers lit their first cigarette before they turned 18. Consider this: 3,000 children start to smoke every day illegally, and 1,000 of them will die sooner because of it. This is a national tragedy that every American should be honor-bound to help prevent. For more than five years we've worked to stop our children from smoking before they start, launching a nationwide campaign to educate them about the dangers of smoking, to reduce their access to tobacco products, and to severely restrict tobacco companies from advertising to young people. If we do these, we'll cut teen smoking by almost half over the next five years. That means if we act now, we have it in our power to stop 3 million children from smoking and to save a million lives as a result. 
 Question: How many children will be stopped from smoking if we act now?


Output: 3 million